1. Use a drug combination, which includes at least one prostaglandin or the same analytical method selected between Trebrostinil, Ilorpost, Cicaprost or Berapast, and at least one phosphatase inhibitor 4 (PDE4), because it helps prevent or treat cystic fibrosis.
FREISIMUTH MICHAEL,GLOECKEL CHRISTINA,KOENIG XAVER,KEUERLEBER SIMON
申请号：
CL2013002234
公开号：
CL2013002234A1
申请日:
2013.08.05
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
Pharmaceutical composition comprising at least a prostacyclin or a Salt thereof and at least one inhibitor of phosphodiesterase 4 (PDE4) that is used to prevent or treat cystic fibrosis； Combination Therapy； and method to increase the Camp level in a cell.<；p>；La presente invenció；n se refiere al uso de una composició；n que comprende al menos una prostaciclina o aná；logo de prostaciclina o una sal farmacé；uticamente aceptable de la misma y al menos un inhibidor de fosfodiesterasa (PDE) 4 para la prevenció；n o tratamiento de fibrosis quí；stica por aumentar selectivemnete los niveles de AMPc en cé；lulas broncoepiteliales. ；<；/p>；
